Electronic Source Documentation in Clinical Investigations（和訳） 2011.1.13
]]>
Related Articles
- FDA Finalizes Comprehensive Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations
- FDA CDER「Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11 – Questions and Answers」
- FDA Guidance Revision for Computer Systems Used in Clinical Investigations
- The Evolution of Electronic Records Regulations: From FDA Part 11’s Tumultuous Past to Today’s Global Harmonization
- Correct Understanding of Electronic Signatures under 21 CFR Part 11
- Understanding Legibility: A Fundamental Requirement for Electronic Records
